PubMed:32829416 JSON TXT

The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

projects that include this document

Unselected / annnotation		Selected / annnotation
LitCovid-GlycoBiology 0 (0) Inflammaging 2 (2) GlyCosmos6-docs 0 (0) Glycosmos6-GlycoEpitope 0 (0) GlyCosmos6-Glycan-Motif-Structure 0 (0) Glycosmos6-MAT 0 (0) sentences 1 (1) GlyCosmos6-Glycan-Motif-Image 0 (0) GlyCosmos15-Glycan 0 (0) Anatomy-MAT 0 (0) HP-phenotype 0 (0) mondo_disease 1 (1) Glycan-GlyCosmos 0 (0) GlyCosmos-GlycoEpitope 0 (0) Lectin-Jamboree 0 (0) NCBITAXON 0 (0) Anatomy-UBERON 0 (0) CL-cell 0 (0) GlyCosmos15-docs 0 (0)